Finnish Medicines Agency Fimea (, the new state authority for medicines in Finland, began running its operations in November 2009. Fimea is responsible for most of the regulation and authorisation work previously handled by the Finnish National Agency for Medicines NAM.

Ms Sinikka Rajaniemi has been appointed as the Director General of Fimea. Ms Rajaniemi previously acted as the Director of the Pharmaceuticals Pricing Board in Finland.

As reported in previous Life Sciences Updates, the establishment of Fimea is part of a larger reorganisation of the pharmaceuticals administration in Finland.